Overproduction of Toxoplasma gondii cyclophilin-18 regulates host cell migration and enhances parasite dissemination in a CCR5-independent manner
© Ibrahim et al.; licensee BioMed Central Ltd. 2014
Received: 29 November 2013
Accepted: 19 March 2014
Published: 25 March 2014
Toxoplasma gondii hijacks host cells to allow it to disseminate throughout a host animal; however, the migratory machinery involved in this process has not been well characterized. We examined the functional role of T. gondii cyclophilin 18 (TgCyp18) in host cell recruitment using recombinant parasites transfected with TgCyp18.
High levels of TgCyp18 enhanced IL-12 production in cysteine-cysteine chemokine receptor 5 (CCR5) knockout mice (CCR5−/−) that had been infected peritoneally with T. gondii. Recruitment of CD11b+ cells to the infection site was enhanced in a CCR5-independent manner. T. gondii spread to several organs, particularly the liver, in a TgCyp18-dependent and CCR5-independent manner. Additionally, CCL5 levels were upregulated in macrophages treated with recombinant protein TgCyp18 and in the peritoneal fluids of the infected CCR5−/− mice. Furthermore, the chemokines involved in macrophage migration, CCL2 and CXCL10, were upregulated in the livers of CCR5−/− mice infected with recombinant parasites that had been transfected with TgCyp18.
TgCyp18 may play a crucial role in macrophage migration, and in assisting with transport of T. gondii via CCR5-independent mechanisms. TgCyp18 may also play a role with CCL5 in the migration of macrophages to the site of infection, and with CCL2 and CXCL10 in the transport of T. gondii-infected cells to the liver.
KeywordsToxoplasma gondii Cyclophilin 18 Cysteine-cysteine chemokine receptor 5 CD11b+ cells Macrophage migration Host cell recruitment
Toxoplasma gondii is an obligate intracellular protozoan parasite that can invade and replicate in the nucleated cells of many animal species, including humans. In several host species, T. gondii is associated with congenital infection and abortion , and it can also cause encephalitis or systemic infections in immunocompromised individuals, particularly those with AIDS . T. gondii can affect pro- and anti-inflammatory host cell signaling in such a way as to maximize parasite multiplication and spread, while maintaining host survival . An aspect of this is the up-regulation of interleukin-12 (IL-12)-dependent production of interferon gamma (IFN-γ), which is critical for host survival during acute toxoplasmosis [4, 5]. To perform this essential role in host defense, immune cells must migrate to the site of infection, where they release IFN-γ, which is critical for macrophage and T cell activation .
Leukocytes are used by T. gondii for transport throughout a host animal . When a host ingests T. gondii-containing cysts or oocysts, free parasites are released into the gut lumen. After invading enterocytes, infected cells secrete chemokines such as chemokine (C-C motif) ligand 2 (CCL2), CCL3, CCL4, and chemokine (C-X-C motif) ligand 2 (CXCL2), to recruit leukocytes into the lamina propria extravascular space . The parasites then spread to several distant tissues such as the spleen, lungs and brain  and T. gondii-infected CD11b+ leukocytes actively travel through the lymphatic system and blood vessels .
T. gondii possesses a unique mechanism for stimulating immune responses and cell migration in the host. Profilin, a T. gondii actin binding protein, enhances the production of IL-12 via myeloid differentiation protein-88 (MyD88) and toll-like receptor (TLR) 11 . It has been reported that T. gondii heat shock protein 70-induced nitric oxide (NO) release was dependent on TLR2, MyD88 and the IL-1 receptor-associated kinase 4 . This immunomodulatory effect also involves cysteine-cysteine chemokine receptor 5 (CCR5) triggering in dendritic cells (DCs) and macrophages, through the secretion of T. gondii cyclophilin (TgCyp18) [12–14]. TgCyp18 appears to induce IL-12 production by interacting directly with CCR5. This effect can be blocked by cyclosporin A [13, 15, 16], suggesting that this is a unique property of TgCyp18.
Interestingly, TgCyp18 recruits immature mouse DCs in vitro; it appears to act as a structural mimic of CCR5-binding ligands, albeit one with no sequence similarity to known host ligands (CCL3, CCL4, CCL5 or CCL8) for this receptor [12, 15, 16]. In a previous study, we showed that TgCyp18 controlled the migration of macrophages and spleen cells in vitro in a dose- and CCR5-dependent manner . However, our in vitro studies also showed that cytokine production and macrophage proliferation occurred in a CCR5-independent manner [13, 14]. Therefore, elucidation of TgCyp18 functions in regard to T. gondii dissemination throughout a host will be important for understanding transport mechanisms in host cells and parasites. This study, therefore, aimed to investigate the role of TgCyp18 in cellular recruitment and parasite dissemination in a CCR5-independent manner through the use of recombinant parasites that had been transfected with TgCyp18.
This study was performed in strict accordance with the recommendations in the Guide for the Care and Use of Laboratory Animals of the Obihiro University of Agriculture and Veterinary Medicine. The protocol was approved by the Committee on the Ethics of Animal Experiments of the Obihiro University of Agriculture and Veterinary Medicine (Permit number 24–15, 25–59). All surgery was performed under isoflurane anesthesia, and all efforts were made to minimize animal suffering.
Parasite and cell cultures
The RH strain of T. gondii and its recombinant derivatives were maintained in Vero (African green monkey kidney epithelial) cells cultured in Eagle’s minimum essential medium (EMEM; Sigma, St Louis, MO) supplemented with 8% heat-inactivated fetal bovine serum (FBS, Nichirei Biosciences, Tokyo, Japan). For tachyzoite purification, parasites and host-cell debris were washed in cold phosphate-buffered saline (PBS), and the final pellet was resuspended in cold PBS, then passed through a 27-gauge needle and a 5.0-μm-pore filter (Millipore, Bedford, MA).
Female C57BL/6 J mice were obtained from CLEA Japan (Tokyo, Japan). CCR5 knockout mice (CCR5−/−, B6.129P2-Ccr5 tm1Kuz /J, Stock No. 005427) were purchased from the Jackson laboratory (Bar Harbor, ME). Animals were housed under specific pathogen-free conditions in the animal facility at the National Research Center for Protozoan Diseases (Obihiro University of Agriculture and Veterinary Medicine, Obihiro, Japan). Animals used in this study were treated and used according to the Guiding Principles for the Care and Use of Research Animals published by the Obihiro University of Agriculture and Veterinary Medicine.
Transfer vector construction
cDNA synthesized from RNA isolated with TRI reagent (Sigma) using a SuperScript™ First-strand Synthesis System for RT-PCR (Invitrogen, Carlsbad, CA) was used as a template to amplify the coding region of the full-length TgCyp18 gene (GenBank accession number U04633.1). The primers used to amplify the TgCyp18 gene contained the NcoI recognition sequence (boldface) in the forward primer (5′-AGC CAT GGA TGA AGC TCG TGC TGT TTT TC-3′) and a NheI site (boldface) in the reverse primer (5′-GTG CTA GCC TCC AAC AAA CCA ATG TCC GT-3′). Amplicons were digested with NcoI and NheI and then ligated into pCR4-TOPO (Invitrogen) to yield pCR4-TOPO-TgCyp18. The nucleotide sequences of recombinant plasmids were analyzed with an ABI 3100 DNA sequencer (Applied Biosystems, Foster City, CA). The pCR4-TOPO-TgCyp18 construct was digested with NcoI and NheI and the resulting product ligated into pHXNTPHA (kindly provided by K.A. Joiner, Yale University), resulting in the plasmid, pHXNTP-TgCyp18HA. Coding sequences corresponding to the full-length TgCyp18 fused to hemagglutinin (HA) were obtained from pHXNTP-TgCyp18HA by NcoI and BglII digestion. Liberated fragments were treated with the Klenow fragment of DNA polymerase I and then inserted into the EcoRV site of pDMG . The pDMG-TgCyp18HA vector contained expression cassettes for the green fluorescent protein (GFP), dihydrofolate (DHFR)-thymidylate synthase (TS) and TgCyp18-HA.
Transfection and selection of T. gondii
Electroporation of tachyzoites was performed as previously described . Briefly, purified T. gondii RH tachyzoites were resuspended (107 cells/ml) in cytomix buffer (120 mM KCl, 0.15 mM CaCl2, 10 mM K2HPO4-KH2PO4, 2 mM EDTA, 5 mM MgCl2, 25 mM HEPES, pH 7.6) supplemented with 2 mM adenosine triphosphate (ATP) and 5 mM glutathione. Cells were electroporated (2.0 kV at 50 W) using a Gene Pulser II (BioRad Laboratories, Tokyo Japan). After transfection, tachyzoites were allowed to infect Vero cells for 18 h in drug-free culture medium to permit phenotypic expression of the DHFR-TS and GFP genes as selectable markers, after which pyrimethamine was added at a final concentration of 1 μM. Polyclonal transfected pyrimethamine-resistant tachyzoite cultures were subjected to plaque purification. Cultures were passaged at least four times in the same medium containing 1% agarose and a single plaque was obtained. Positive clones were identified by indirect fluorescent antibody tests (IFATs) using an anti-HA.11 mouse monoclonal antibody (mAb; Covance, Emeryville, CA). The resultant recombinant T. gondii clones, pDMG-TgCyp18HA and pDMG, are hereafter designated RH-OE and RH-GFP, respectively. The TgCyp18 expression levels among three independent clones from each transfectant were examined by western blotting and TgCyp18 secretion assays, and a representative clone was selected for further study.
Western blot analysis
Tachyzoites (1 × 106) of wild type parasites (RH-WT), RH-OE or RH-GFP were harvested, washed and suspended in 10 μl of PBS, sonicated, and then mixed with 10 μl of 2 × sodium dodecyl sulfate (SDS) gel-loading buffer [62.5 mM Tris–HCl pH 6.8, 2% (w/v) SDS, 140 mM 2-mercaptoethanol, 10% (w/v) glycerol and 0.02% (w/v) bromophenol blue] under reducing conditions. Samples were heated at 95°C for 5 min and separated on a 15% polyacrylamide gel. After SDS polyacrylamide gel electrophoresis the protein bands in the gel were transferred to a nitrocellulose membrane (Whatman GmbH, Dassel, Germany). After washing twice with PBS containing 0.05% (v/v) Tween 20 (PBS-T), membranes were blocked with PBS containing 3% (w/v) skimmed milk (PBS-SM) for 12 h at 4°C. After two further washes, the membranes were incubated with an anti-TgCyp18 rabbit antibody at 1:500 , an anti-TgSAG1 mAb (1:1000; Advanced Immunochemical Inc., Long Beach, CA) or an anti-HA.11 mAb (1:1000; Covance) for 1 h at room temperature. After washing three times, the membranes were incubated with horseradish peroxidase (HRP)-conjugated goat anti-mouse immunoglobulin G (1:1000; Amersham Pharmacia Biotech, Piscataway, NJ) diluted in PBS-SM, for 1 h at 37°C. After washing three times, the proteins were visualized on X-ray film using ECL™ western blotting detection reagents (GE Healthcare UK Ltd., Buckinghamshire, UK) according to the manufacturer’s recommendations.
Parasite infections in mice
Parasites purified from in vitro cultures were washed in sterile PBS and tachyzoites (5 × 102 – 1 × 103) were inoculated intraperitoneally into mice. Three or five days after the infection, cells were collected from the peritoneal cavity of naïve or parasite-infected mice by peritoneal washing with 5 ml of cold PBS. After harvesting, the cells were centrifuged at 800 × g for 10 min and suspended in cold PBS. These cells were then subjected to flow cytometry. Supernatants were used to measure TgCyp18, IL-12, CCL2, CCL5 and CXCL10 production. To determine the parasite burden and chemokine expression levels in the mice, tissues including the brain, liver, lungs and spleen from T. gondii infected and uninfected animals were collected at 0, 3 and 5 days post-infection (dpi).
Sandwich enzyme-linked immunosorbent assay (ELISA) detection of TgCyp18
The presence of TgCyp18 in mouse ascites fluid and TgCyp18 secreted by extracellular parasites in infected mice was determined by a sandwich ELISA as described previously . To detect TgCyp18 from extracellular tachyzoites, purified T. gondii tachyzoites (3 × 107) were incubated in 1.5 ml of GIT medium (Nihon Pharmaceutical Co., Ltd, Tokyo, Japan) at 37°C. Before transferring parasite suspensions from ice to 37°C for a secretion assay, 250 μl of the parasite suspension was removed and processed as the time zero reading. The remainder of the parasite suspension was incubated at 37°C in a water bath. After 15, 30, 60, and 120 min, 250 μl of parasite suspension was removed. The culture supernatants were centrifuged (760 × g for 10 min at 4°C, then 7000 × g for 10 min at 4°C) together with the ascites fluid from the in vivo experiment, and then subjected to sandwich ELISA.
Microtiter plates were coated with 1 μg of rabbit anti-rTgCyp18 polyclonal IgG  diluted in 0.05 M carbonate buffer (pH 9.6), which was used as the capture antibody at 4°C overnight. Blocking was performed with a blocking solution (PBS-SM, pH 7.2) at 37°C for 2 h. Microtiter plates were incubated at 37°C for 30 min with each supernatant in triplicate. After washing six times with PBS-T, anti-TgCyp18 mouse serum (1:100) was added to each well as the detection antibody. After a further six washes, the plates were incubated with HRP-conjugated goat anti-mouse IgG (1:2500; Amersham Pharmacia Biotech). Binding was visualized with substrate solution [0.3 mg/ml 2,2'-azino-bis-(3-ethylbenz-thiazoline-6-sulfonic acid), 0.1 M citric acid, 0.2 M sodium phosphate, 0.003% H2O2]. Absorbance at 415 nm was measured using a MTP-500 microplate reader (Corona Electric, Tokyo, Japan). The TgCyp18 concentration in each sample was calculated by standardization against the recombinant TgCyp18 protein .
Ascetic fluid was collected for measurement of total IL-12, CCL2, CCL5 and CXCL10 levels using ELISA kits (IL-12: Pierce Biotechnology Inc., Rockford, IL; CCL2, CCL5 and CXCL10: R&D Systems, Minneapolis, MN) according to the manufacturer’s recommendations.
Anti-mouse CD11b mAb, anti-mouse CCR5 mAb, anti-mouse CD3e (CD3ϵ chain) mAb, and hamster anti-mouse CD11c (HL3) mAb were purchased from BD Biosciences (San Jose, CA) and labeled with phycoerythrin (PE). After washing with cold PBS, peritoneal cells were suspended in cold PBS containing 0.5% bovine serum albumin, treated with Fc Block™ (BD Biosciences, San Jose, CA, USA) and subsequently incubated with PE-labeled anti-mouse antibodies for 30 min at 4°C followed by a final washing step with cold PBS. T. gondii-infected cells were GFP+. Labeled cells (1 × 104) were examined using an EPICS® XL flow cytometer (Beckman Coulter, Hialeah, FL). The absolute number of each marker indicated below was calculated as follows: the absolute cell number = the total host cell number × (the percentage of marker+ cells/100) × (the percentage of gated cells observed by flow cytometry/100). Infected cells in peritoneal fluids were detected by double signals, comprising CCR5+, CD11b+, CD11c+ or CD3+ cell markers labeled with PE using anti-CCR5, anti-CD11b, anti-CD11c and anti-CD3 mAbs, and GFP signaling of the parasites.
DNA isolation and quantitative PCR (qPCR) detection of T. gondii
Tissues (brain, liver, lungs and spleen) and peritoneal fluids from T. gondii-infected animals were collected at 0, 3 and 5 dpi. DNA was extracted from tissues by resuspending the samples in extraction buffer (0.1 M Tris–HCl pH 9.0, 1% SDS, 0.1 M NaCl, 1 mM EDTA, 1 mg/ml proteinase K) followed by incubation at 55°C. DNA was purified by phenol-chloroform extraction and ethanol precipitation. Amplification of parasite DNA was performed using primers specific for the T. gondii B1 gene (5'-AAC GGG CGA GTA GCA CCT GAG GAG A-3' and 5'-TGG GTC TAC GTC GAT GGC ATG ACA AC-3'), which is present in all known strains of this species of parasite . The PCR mixture (25 μl) contained 1 × SYBR Green PCR Buffer, 2 mM MgCl2, 200 μM each dNTP, 400 μM dUTP, 0.625 U of AmpliTaq Gold DNA polymerase, and 0.25 U of AmpErase uracil-N-glycosylase (UNG) (AB Applied Biosystems, Carlsbad, CA), 0.5 μ moles of each primer and 50 ng of genomic DNA. Amplification was performed by a standard protocol recommended by the manufacturer (2 min at 50°C, 10 min at 95°C, then 40 cycles of 95°C for 15 s and 60°C for 1 min). Amplification, data acquisition, and data analysis were carried out in an ABI 7900HT Prism Sequence Detector (AB Applied Biosystems), and cycle threshold values (Ct) were exported to Microsoft Excel for analysis. Parasite loads were estimated by comparison with internal controls, with the level of the internal control calculated per parasite . Briefly, numbers of parasites were calculated by interpolation on a standard curve, with Ct values plotted against a known concentration of parasites. After amplification, PCR product melting curves were acquired via a stepwise temperature increase from 60°C to 95°C. Data analyses were conducted with Dissociation Curves version 1.0 f (AB Applied Biosystems).
Peritoneal macrophage cultures
Mouse peritoneal macrophages were collected from mice four days after their intraperitoneal injections with 1 ml of 4.05% brewer modified BBL™ thioglycolate medium (Becton Dickinson, Sparks, MD). Collected cells were washed with 5 ml of cold PBS, then centrifuged at 800 × g for 10 min and suspended in RPMI 1640 medium (Sigma) containing 10% FBS. The macrophage suspension was then added to 24-well tissue culture microplates (1 × 106 cells/well). Suspensions were incubated at 37°C for 3 h, washed thoroughly to remove non-adherent cells, and incubated further at 37°C. Macrophages were treated with purified TgCyp18 recombinant protein  at 37°C for 20 h. Cells were then harvested for qPCR analysis to determine their chemokine expression levels.
qPCR analysis of chemokine expression
Total RNA was extracted from cells or homogenized tissues using Tri reagent (Sigma). Reverse transcription of RNA was performed using Superscript II Reverse Transcriptase (Gibco BRL) in a final volume of 25 μl. qPCR was carried out as described above. The relative amounts of all mRNAs were calculated using the comparative Ct method (Perkin-Elmer). Glyceraldehyde-3-phosphate dehydrogenase (GAPDH) mRNA was used as a control. Specific primer sequences for mouse CCL2 (5'-GGC TCA GCC AGA TGC AGT TAA-3' and 5'-CCT ACT CAT TGG GAT CAT CTT GCT-3'), mouse CCL3 (5'-CCA GCC AGG TGT CAT TTT TCC T-3' and 5'-TCC AAG ACT CTC AGG CAT TCA GT-3'), mouse CCL4 (5'-CTC CAA GCC AGC TGT GGT ATT C-3' and 5'-CTC CAA GTC ACT CAT GTA ACT CAG TGA-3'), mouse CCL5 (5'-CCA ATC TTG CAG TCG TGT TTG T-3' and 5'-CAT CTC CAA ATA GTT GAT GTA TTC TTG AAC-3'), mouse CCL6 (5'-TGC CAC ACA GAT CCC ATG TAA-3' and 5'-TGA TGC CCG GCT TGA TG-3'), mouse CCL12 (5'-GAG AAT CAC AAG CAG CCA GTG T-3' and 5'-GCA CAG ATC TCC TTA TCC AGT ATG G-3'), mouse CXCL10 (5'-GAC GGT CCG CTG CAA CTG-3' and 5'-CTT CCC TAT GGC CCT CAT TCT-3'), mouse CX3CL1 (5'-CCG AGG CAC AGG ATG CA-3' and 5'-TGT CAG CCG CCT CAA AAC TT-3'), and mouse GAPDH (5'-TGT GTC CGT CGT GGA TCT GA-3' and 5'-CCT GCT TCA CCA CCT TCT TGA T-3') were designed using Primer Express (Applied Biosystems).
Data are expressed as the mean ± the standard deviation, or as scatter diagrams. Various assay conditions were evaluated using a Student’s t-test or an analysis of variance (ANOVA) test followed by Tukey’s multiple comparison. *P < 0.05, **P < 0.01, ***P < 0.001.
Characterization of recombinant T. gondii
Detection of TgCyp18 in extracellular parasites and infected mice
Extracellular RH-OE parasites spontaneously secreted higher levels of TgCyp18 into the medium compared with RH-WT or RH-GFP (Figure 1C). Time-dependent secretion of TgCyp18 by the extracellular parasites was observed. In addition, statistically significant higher levels of TgCyp18 were detected in the ascetic fluid from RH-OE-infected mice at 3 and 5 dpi compared with that of the RH-GFP-infected animals (Figure 1D).
Effects of TgCyp18 induction on IL-12 production in vivo
Effects of TgCyp18 on immune cell recruitment
Effects of TgCyp18 on parasite trafficking properties
Effects of TgCyp18 on expression of the CCR5 ligands and chemokines involved in macrophage migration in vitro and in vivo
Control of acute toxoplasmosis relies on a potent Th1 cell response that requires IL-12 and IFN-γ production, which are generated through both innate and adaptive responses [21, 22]. It appears that Toxoplasma is unique in that it possesses two mechanisms that trigger IL-12 production in DCs and macrophages [3, 12, 23]. One of these mechanisms is dependent upon the common adaptor protein MyD88, and is likely to involve TLR11 [3, 10, 23]. The other mechanism is dependent upon TgCyp18, which is released by extracellular tachyzoites, triggering IL-12 production through binding to CCR5 . Recently, our group reported that TgCyp18 induced production of NO, TNF-α and IL-12p40 in macrophages, and also up-regulated the production of IFN-γ and IL-6 in these cells . In the present study, the levels of IL-12 in the ascetic fluid of RH-OE-infected CCR5−/− mice were significantly higher than those in RH-GFP-infected CCR5−/− mice, suggesting that cytokine production arose via TgCyp18-dependent and CCR5-independent mechanisms. TgCyp18 stimulated IL-12 production in macrophages  and DCs . Therefore, macrophages and DCs both play a role in IL-12 production in the present study. Further investigations are required to distinguish the relative contributions made by these cells. These results suggest that CCR5-independent accumulation of inflammatory cells at the site of infection might produce higher levels of pro-inflammatory cytokines in CCR5−/− mice.
The ability of T. gondii to attract, invade, and survive inside immune cells (T cells, DCs and macrophages), along with the migratory properties of DCs and macrophages that allow parasite dissemination around the host have been reported previously [7, 24]*. Our results revealed that while T. gondii could infect CD3+, CD11c+, and CD11b+ cells, it exhibited a preference for CD11b+. We observed enhanced recruitment of CD11b+ cells after infection with RH-OE. This chemotactic effect of TgCyp18 was correlated with the ability of RH-OE to increase CCR5 expression levels. Thus, overproduction of TgCyp18 during RH-OE infection enhanced cellular recruitment. Recruitment of CD11b+ cells in CCR5−/− mice infected with RH-OE was also higher than that in RH-GFP-infected mice. Additionally, there was no significant difference in the recruitment of CD11b+ cells between WT and CCR5−/− mice that were infected peritoneally with RH-GFP tachyzoites. Recently, our group demonstrated that recombinant TgCyp18 controlled the in vitro migration of macrophages and lymphocytes in CCR5-dependent and -independent ways . Therefore, the results presented here suggest that the TgCyp18-induced cell migration occurred in a CCR5-independent way in our in vivo experimental model.
Migration of macrophages and lymphocytes to the site of infection would enhance T. gondii invasion into these cells, after which the parasite-infected cells, such as CD11b+ leukocytes, are transported to other organs . Our quantitative PCR analyses revealed that infection with RH-OE resulted in an increased parasitic load in the liver compared with RH-GFP infection. These results suggest that cells recruited by TgCyp18 are used to shuttle the parasite to other organs. In general, chemokines and their receptors play an important role in the migration of immune cells. A previous study showed that an early burst of CCR5 ligand production occurred in the tissue of WT and CCR5−/− mice by day 5 after oral infection with T. gondii strain 76 k cysts . Our present study showed that recombinant TgCyp18 increased the expression levels of CCL5 in macrophages. In addition, significantly higher levels of CCL5 were detected in the peritoneal fluids of CCR5−/− mice infected RH-OE. Moreover, CCL5 levels in the livers of WT mice infected with RH-OE at 5 dpi were higher than those in the other experimental groups. Consistent with our findings, a previous study showed that the parasite numbers in the livers of CCR5−/− mice were higher than those of the C57BL/6 wild-type animals, while the parasite numbers were similar in other organs of the WT and CCR5−/− mice . Therefore, TgCyp18-mediated CCL5 production might contribute to macrophage migration to the site of infection and the transport of T. gondii-infected cells to the liver. Besides CCR5, CCL5 has been shown to interact with other receptors, including CCR3 and CCR1. Therefore, activation of CCR1- and CCR3-signaling may contribute to CCL5-mediated pathology during T. gondii infection. Hence, the chemokines up-regulated in CCR5−/− mice infected with RH-OE may play a crucial role in CCR5-independent macrophage migration.
To test this idea in our study, the expression levels of chemokines related to macrophage migration were investigated. In vitro analysis showed that TgCyp18 increased the expression of CCL6 in a CCR5 independent manner. However, the in vivo data showed that a higher level of CCL6 was observed in the livers of the CCR5−/− mice infected RH-GFP at 3 dpi compared with those infected with RH-OE. Although we do not know the reason for the difference between the in vitro and in vivo data, it is possible that CCL6 expression might have been induced before 3 dpi in the livers of the CCR5−/− mice infected with RH-OE. It is interesting to note that CCL2 expression was slightly increased in macrophages treated with recombinant TgCyp18. Moreover, the expression levels of CCL2 and CXCL10 were significantly higher at 3 dpi in the livers of CCR5−/− mice infected with RH-OE compared with the uninfected mice. Thus, TgCyp18-mediated production of CCL2 and CXCL10 in the liver may trigger transport of T. gondii-infected macrophages via a CCR2 and CXCR3-dependent mechanism, respectively. CCR2−/− mice have profound defects in monocyte recruitment although constitutive trafficking remains unaffected . CCR2−/− mice or CCL2−/− mice failed to recruit Gr1+ inflammatory monocytes, which are required for mucosal resistance to T. gondii, or to control systemic toxoplasmosis by intraperitoneal infection . Furthermore, another group reported that the CXCR3 ligands, CXCL9, CXCL10 and CXCL11, were induced markedly at the levels in the spleen, lung, and liver following infection with T. gondii. Induction of these chemokines was similar in WT and CCR5−/− mice up to day 5 . CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis . These results suggest that CCR2 and CCL2, or CXCR3 and its ligands, play a crucial role in cell migration and control of T. gondii infection.
Diana et al.  showed that a T. gondii excreted-secreted antigen induced recruitment and migration of human DCs in a CCR5-dependent fashion. Other studies in mice have reported that T. gondii activates DCs and triggers their migration to the spleen to activate proliferation of T cells, or to potentiate parasite dissemination [25, 33]. TgCyp18 can attract mouse DCs in vitro. CCR5 plays an important role in the migration of intraepithelial CD8+ T cells, and in the regulation of an inflammatory response following T. gondii infection . CCR5 also has a role in the migration of NK cells, with severe deleterious effects observed in infected mice . Thus, it has been shown that increased immune cell migration is involved in the pathogenesis and control of infection with T. gondii. In the present study, based on survival rates, significant differences were not detected in the parasite-challenged (RH-WT, RH-GFP and RH-OE) mice (data not shown). All mice (n = 6) infected intraperitoneally with 1,000 tachyzoites died by 8–9 dpi. All mice (n = 4) infected intraperitoneally with 100 tachyzoites died by 11–15 dpi. Histopathological lesions in livers, spleens and lungs were observed in all mice infected with RH-GFP and RH-OE, but there were no remarkable differences in the severity of the lesions among the experimental groups (Additional file 2: Figure S2). This was probably related to the high virulence of the T. gondii type I strain. In addition, to determine whether macrophages assisted with T. gondii dissemination in the mice, C57BL/6 mice were subject to macrophage depletion by treatment with clodronate liposome, and then challenged with the T. gondii PLK strain (type II). The survival rates of the clodronate-treated and untreated mice were 71% and 43% (n = 7), respectively. Therefore, it appears likely that macrophages assisted with T. gondii dissemination in the mice. However, the pathogenesis of infection with the RH strain is quite different from that of infection with the PLK strain. Hence, further investigations are required to confirm the contribution of TgCyp18 to parasite pathogenesis and the role of macrophages in parasite dissemination.
The recombinant strain (RH-OE) of the parasite expresses TgCyp18 fused to HA. Therefore, it is unclear whether the effects of infection with RH-OE were due to TgCyp18 or HA (or both). To address this, we generated a recombinant T. gondii parasite that expressed the TgCyp18-HA fusion protein as mutants (17GEH19 to 17AAA19 and 149RP150 to 149YV150), which when tested, exhibited reduced interactions with CCR5 (RH-DN, Additional file 3: Figure S3). There was no significant difference in IL-12 production levels in ascites fluid and recruitment of immune cells between the mice infected with RH-GFP and RH-DN (Additional file 4: Figure S4). Therefore, these data suggest that the effects of infection with RH-OE were not due to the HA tag. In addition, the interaction between TgCyp18 and CCR5 played a role in IL-12 production and recruitment of immune cells in the wild type mice.
Taken together, it appears that TgCyp18 might enhance its effects directly through binding with CCR5 and/or another receptor or receptors not yet identified. Regarding TgCyp18-CCR5 dependent or independent responses, there are two explanations that might clarify our observations. First, optimal production of TgCyp18 may under normal circumstances work on CCR5 and/or other receptor(s) to recruit immune cells that produce cytokines. This possibility seems obvious in view of our previous results that showed that TgCyp18 controlled the in vitro migration of macrophages and spleen cells in a CCR5-dependent manner . In contrast, TgCyp18 may initiate cytokine production and macrophage proliferation in a CCR5-independent manner [13, 14]. Second, it is possible that stimulation of host cells with TgCyp18 via CCR5 and/or other receptor(s) could trigger expression of chemokine receptors and its ligands for cell migration. Increased CCL5 levels in the livers of the wild-type mice infected with RH-OE parasites indicates that parasite migration to this organ occurred in a TgCyp18- and CCR5-dependent manner. Furthermore, parasite migration, which occurred in a CCR5-independent and TgCyp18-dependent way, can be explained by the higher levels of CCL2 and CXCL10 in the liver and CCL5 in the ascites fluid of CCR5−/− mice infected with RH-OE. Thus, the present results suggest that TgCyp18 has the ability to enhance host-cell migration via CCL5 and parasite dissemination by CCL2 and CXCL10 in a CCR5-independent manner.
We determined that TgCyp18 plays a crucial role in the migration of CD11b+ cells to the site of T. gondii infection, and that the mechanisms responsible could be both dependent on and independent of CCR5 expression levels. Enhanced migration of host cells will mediate T. gondii transport to organs, especially the liver. We have shown that there are several options available to T. gondii for completing its infection cycle, one of which is CCR5-dependent, others of which involve TgCyp18-mediated production of chemokines in a CCR5-independent manner. Additional work will be required to clarify the precise role that TgCyp18 plays in parasite-infected host cells and in parasite migration in the host.
The authors are grateful to Drs. J. C. Boothroyd, (Stanford University), K. A. Joiner (Yale University), and D. S. Roos (University of Pennsylvania) for supplying the DNA constructs used to develop recombinant T. gondii. The authors would also like to thank Youko Matsushita, Megumi Noda, Yoshie Imura and Myagmarsuren Punsantsogvoo for their help with the experiments. Hany M. Ibrahim was supported by the Egyptian Ministry of High Education and Scientific Research. This research was supported by the Japan Society for the Promotion of Science through the Funding Program for Next Generation World-Leading Researchers (NEXT Program), initiated by the Council for Science and Technology Policy (2011/LS003).
- Black MW, Boothroyd JC: Lytic cycle of Toxoplasma gondii. Microbiol Mol Biol Rev. 2000, 64: 607-623. 10.1128/MMBR.64.3.607-623.2000.PubMed CentralView ArticlePubMed
- Luft BJ, Remington JS: AIDS commentary. Toxoplasmic encephalitis. J Infect Dis. 1988, 157: 1-6. 10.1093/infdis/157.1.1.View ArticlePubMed
- Denkers EY: From cells to signaling cascades: manipulation of innate immunity by Toxoplasma gondii. FEMS Immunol Med Microbiol. 2003, 39: 193-203. 10.1016/S0928-8244(03)00279-7.View ArticlePubMed
- Gazzinelli RT, Hieny S, Wynn TA, Wolf S, Sher A: Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and Induces resistance in T-cell-deficient hosts. Proc Natl Acad Sci U S A. 1993, 90: 6115-6119. 10.1073/pnas.90.13.6115.PubMed CentralView ArticlePubMed
- Hunter CA, Subauste CS, Van Cleave VH, Remington JS: Production of gamma interferon by natural killer cells from Toxoplasma gondii-infected SCID mice: regulation by interleukin-10, interleukin-12, and tumor necrosis factor alpha. Infect Immun. 1994, 62: 2818-2824.PubMed CentralPubMed
- Boehm U, Klamp T, Groot M, Howard JC: Cellular responses to interferon-gamma. Annu Rev Immunol. 1997, 15: 749-795. 10.1146/annurev.immunol.15.1.749.View ArticlePubMed
- Courret N, Darche S, Sonigo P, Milon G, Buzoni-Gâtel D, Tardieux I: CD11c- and CD11b-expressing mouse leukocytes transport single Toxoplasma gondii tachyzoites to the brain. Blood. 2006, 107: 309-316. 10.1182/blood-2005-02-0666.PubMed CentralView ArticlePubMed
- Luangsay S, Kasper LH, Rachinel N, Minns LA, Mennechet FJ, Vandewalle A, Buzoni-Gatel D: CCR5 mediates specific migration of Toxoplasma gondii-primed CD8 lymphocytes to inflammatory intestinal epithelial cells. Gastroenterology. 2003, 125: 491-500. 10.1016/S0016-5085(03)00903-X.View ArticlePubMed
- Zenner L, Darcy F, Capron A, Cesbron-Delauw MF: Toxoplasma gondii: kinetics of the dissemination in the host tissues during the acute phase of infection of mice and rats. Exp Parasitol. 1998, 90: 86-94. 10.1006/expr.1998.4301.View ArticlePubMed
- Yarovinsky F, Zhang D, Andersen JF, Bannenberg GL, Serhan CN, Hayden MS, Hieny S, Sutterwala FS, Flavell RA, Ghosh S, Sher A: TLR11 activation of dendritic cells by a protozoan profilin-like protein. Science. 2005, 308: 1626-1629. 10.1126/science.1109893.View ArticlePubMed
- Mun HS, Aosai F, Norose K, Piao LX, Fang H, Akira S, Yano A: Toll-like receptor 4 mediates tolerance in macrophages stimulated with Toxoplasma gondii-derived heat shock protein 70. Infect Immun. 2005, 73: 4634-4642. 10.1128/IAI.73.8.4634-4642.2005.PubMed CentralView ArticlePubMed
- Aliberti J, Valenzuela JG, Carruthers VB, Hieny S, Andersen J, Charest H, Reis e Sousa C, Fairlamb A, Ribeiro JM, Sher A: Molecular mimicry of a CCR5 binding-domain in the microbial activation of dendritic cells. Nat Immunol. 2003, 4: 485-490. 10.1038/ni915.View ArticlePubMed
- Ibrahim HM, Bannai H, Xuan X, Nishikawa Y: Toxoplasma gondii cyclophilin 18-mediated production of nitric oxide induces bradyzoite conversion in a CCR5-dependent manner. Infect Immun. 2009, 77: 3686-3695. 10.1128/IAI.00361-09.PubMed CentralView ArticlePubMed
- Ibrahim HM, Xuan X, Nishikawa Y: Toxoplasma gondii cyclophilin 18 regulates the proliferation and migration of murine macrophages and spleen cells. Clin Vaccine Immunol. 2010, 17: 1322-1329. 10.1128/CVI.00128-10.PubMed CentralView ArticlePubMed
- Yarovinsky F, Andersen JF, King LR, Caspar P, Aliberti J, Golding H, Sher A: Structural determinants of the anti-HIV activity of a CCR5 antagonist derived from Toxoplasma gondii. J Biol Chem. 2004, 279: 53635-53642. 10.1074/jbc.M410550200.View ArticlePubMed
- Bell A, Monaghan P, Page AP: Peptidyl-prolyl cis-trans isomerases (immunophilins) and their roles in parasite biochemistry, host-parasite interaction and antiparasitic drug action. Int J Parasitol. 2006, 36: 261-276. 10.1016/j.ijpara.2005.11.003.View ArticlePubMed
- Nishikawa Y, Xuenan X, Makala L, Vielemeyer O, Joiner KA, Nagasawa H: Characterisation of Toxoplasma gondii engineered to express mouse interferon-gamma. Int J Parasitol. 2003, 33: 1525-1535. 10.1016/S0020-7519(03)00204-2.View ArticlePubMed
- Sibley LD, Messina M, Niesman IR: Stable DNA transformation in the obligate intracellular parasite Toxoplasma gondii by complementation of tryptophan auxotrophy. Proc Natl Acad Sci U S A. 1994, 91: 5508-5512. 10.1073/pnas.91.12.5508.PubMed CentralView ArticlePubMed
- Contini C, Seraceni S, Cultrera R, Incorvaia C, Sebastiani A, Picot S: Evaluation of a Real-time PCR-based assay using the light-cycler system for detection of Toxoplasma gondii bradyzoite genes in blood specimens from patients with toxoplasmic retinochoroiditis. Int J Parasitol. 2005, 35: 275-283. 10.1016/j.ijpara.2004.11.016.View ArticlePubMed
- Tanaka S, Nishimura M, Ihara F, Yamagishi J, Suzuki Y, Nishikawa Y: Transcriptome Analysis of Mouse Brain Infected with Toxoplasma gondii. Infect Immun. 2013, 81: 3609-3619. 10.1128/IAI.00439-13.PubMed CentralView ArticlePubMed
- Buzoni-Gatel D, Kasper LH: Innate Immunity in Toxoplasma gondii infection. Toxoplasma gondii The model apicomplexan: perspectives and methods. Edited by: Weiss LM, Kim K. 2007, London: Academic Press Elsevier, 593-607.View Article
- Roberts CW, Gazzinelli RT, Khan IA, Nowakowska D, Esquivel A, Mcleod R: Adaptive immunity and genetics of the host immune response. Toxoplasma gondii The model apicomplexan: perspectives and methods. Edited by: Weiss LM, Kim K. 2007, London: Academic Press Elsevier, 610-720.
- Scanga CA, Aliberti J, Jankovic D, Tilloy F, Bennouna S, Denkers EY, Medzhitov R, Sher A: Cutting edge: MyD88 is required for resistance to Toxoplasma gondii infection and regulates parasite-induced IL-12 production by dendritic cells. J Immunol. 2002, 168: 5997-6001.View ArticlePubMed
- Buzoni-Gatel D, Schulthess J, Menard LC, Kasper LH: Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections. Cell Microbiol. 2006, 8: 535-544. 10.1111/j.1462-5822.2006.00692.x.View ArticlePubMed
- Lambert H, Hitziger N, Dellacasa I, Svensson M, Barragan A: Induction of dendritic cell migration upon Toxoplasma gondii infection potentiates parasite dissemination. Cell Microbiol. 2006, 8: 1611-1623. 10.1111/j.1462-5822.2006.00735.x.View ArticlePubMed
- Persson EK, Agnarson AM, Lambert H, Hitziger N, Yagita H, Chambers BJ, Barragan A, Grandien A: Death receptor ligation or exposure to perforin trigger rapid egress of the intracellular parasite Toxoplasma gondii. J Immunol. 2007, 179: 8357-8365.View ArticlePubMed
- Khan IA, Thomas SY, Moretto MM, Lee FS, Islam SA, Combe C, Schwartzman JD, Luster AD: CCR5 is essential for NK cell trafficking and host survival following Toxoplasma gondii infection. PLoS Pathog. 2006, 2: e49-10.1371/journal.ppat.0020049.PubMed CentralView ArticlePubMed
- Kuziel WA, Morgan SJ, Dawson TC, Griffin S, Smithies O, Ley K, Maeda N: Severe reduction in leukocyte adhesion and monocyte extravasation in mice deficient in CC chemokine receptor 2. Proc Natl Acad Sci U S A. 1997, 94: 12053-12058. 10.1073/pnas.94.22.12053.PubMed CentralView ArticlePubMed
- Dunay IR, Damatta RA, Fux B, Presti R, Greco S, Colonna M, Sibley LD: Gr1(+) inflammatory monocytes are required for mucosal resistance to the pathogen Toxoplasma gondii. Immunity. 2008, 29: 306-317. 10.1016/j.immuni.2008.05.019.PubMed CentralView ArticlePubMed
- Robben PM, LaRegina M, Kuziel WA, Sibley LD: Recruitment of Gr-1+ monocytes is essential for control of acute toxoplasmosis. J Exp Med. 2005, 201: 1761-1769. 10.1084/jem.20050054.PubMed CentralView ArticlePubMed
- Norose K, Kikumura A, Luster AD, Hunter CA, Harris TH: CXCL10 is required to maintain T-cell populations and to control parasite replication during chronic ocular toxoplasmosis. Invest Ophthalmol Vis Sci. 2011, 52: 389-398. 10.1167/iovs.10-5819.PubMed CentralView ArticlePubMed
- Diana J, Vincent C, Peyron F, Picot S, Schmitt D, Persat F: Toxoplasma gondii regulates recruitment and migration of human dendritic cells via different soluble secreted factors. Clin Exp Immunol. 2005, 141: 475-484. 10.1111/j.1365-2249.2005.02856.x.PubMed CentralView ArticlePubMed
- Sher A, Hieny S, Charest H, Scharton-Kersten T, Collazo C, Germain RN, Reis e Sousa C: The role of dendritic cells in the initiation of host resistance to Toxoplasma gondii. Adv Exp Med Biol. 1998, 452: 103-110. 10.1007/978-1-4615-5355-7_12.View ArticlePubMed
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.